Literature DB >> 23229679

Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand.

Charat Thongprayoon1, Pakpoom Tantrachoti, Parkpoom Phatharacharukul, Supranee Buranapraditkun, Jettanong Klaewsongkram.   

Abstract

Several immune disorders are often associated with thymoma. The aim of this study was to analyze the correlation between clinicopathological features of Thai patients with thymoma and concomitant immune-mediated diseases. Medical records of 87 patients diagnosed with thymoma during a 10-year period were retrospectively reviewed. Peripheral blood T cell subsets along with cytokine responses in 15 thymoma patients and 15 healthy controls were comparatively analyzed. The results demonstrated that thymoma type AB and B2 were the most common types among patients diagnosed with thymoma. The most common presentation was incidentaloma, followed by local chest symptoms and autoimmune diseases. The prevalence of autoimmune diseases, immunodeficiency states, and secondary neoplasms was 34.5, 10.3, and 10.3 %, respectively. Autoimmune diseases were most frequently found in thymoma type B2 and sometimes associated with clinical immunodeficiency, although classic Good's syndrome was rare. Patients with thymoma had significantly lower percentage CD4(+ve) T cells and interferon γ response, but higher percentage regulatory T cells than those in healthy controls. This study indicated that the aberrant immunologic disorders comprising autoimmune diseases, immunodeficiency states, and secondary neoplasms were found in almost 40 % of Thai patients with thymoma and possibly related to defectiva cytokine responses and altered T cell subsets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229679     DOI: 10.1007/s00005-012-0207-9

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  5 in total

1.  Mutation in West Nile Virus Structural Protein prM during Human Infection.

Authors:  Yaniv Lustig; Robert S Lanciotti; Musa Hindiyeh; Nathan Keller; Ron Milo; Shlomo Mayan; Ella Mendelson
Journal:  Emerg Infect Dis       Date:  2016-09-15       Impact factor: 6.883

2.  Aberrant Peripheral Immune Function in a Good Syndrome Patient.

Authors:  Xian Chen; Jie-Xin Zhang; Wen-Wen Shang; Wei-Ping Xie; Shu-Xian Jin; Fang Wang
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

3.  Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.

Authors:  Feng Guo; Chun-Yang Wang; Shuo Wang; Jun Zhang; Yi-Jie Yan; Zhi-Yu Guan; Fan-Jie Meng
Journal:  Thorac Cancer       Date:  2019-02-07       Impact factor: 3.500

4.  Prognostic Model of Eleven Genes Based on the Immune Microenvironment in Patients With Thymoma.

Authors:  Ying Yang; Liqing Xie; Chen Li; Liangle Liu; Xiuzhi Ye; Jianbang Han
Journal:  Front Genet       Date:  2022-02-11       Impact factor: 4.599

5.  Immunological signature of patients with thymic epithelial tumors and Good syndrome.

Authors:  Anna Maria Malfitano; Vittoria D'Esposito; Pietro De Placido; Marianna Tortora; Margaret Ottaviano; Erica Pietroluongo; Rocco Morra; Brigitta Mucci; Fabiana Napolitano; Liliana Montella; Mario Giuliano; Sabino De Placido; Daniela Terracciano; Giovannella Palmieri; Pietro Formisano
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.